financetom
Business
financetom
/
Business
/
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
Nov 11, 2024 5:52 AM

08:28 AM EST, 11/11/2024 (MT Newswires) -- Full Circle Lithium ( FCLIF ) , a U.S.-based lithium-products manufacturer, on Monday said that sales of FCL-X, the company's lithium-ion battery fire-extinguishing agent, has surpassed US$300,000.

"We are very pleased to see that we achieved meaningful non-recurring sales of FCL-X in all product lines in the past few weeks even though we have just begun our marketing and sales efforts, including signing up with US specialty fire safety distributor AEST Fire & Safety," said CEO Carlos Vicens.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Amazon Wants Workers Back in Office 5 Days a Week
--Amazon Wants Workers Back in Office 5 Days a Week
Sep 16, 2024
01:41 PM EDT, 09/16/2024 (MT Newswires) -- Price: 184.50, Change: -1.99, Percent Change: -1.07 ...
What's Going On With Exicure Shares Monday?
What's Going On With Exicure Shares Monday?
Sep 16, 2024
Exicure, Inc. ( XCUR ) stock is trading higher on Monday after the company entered into debt-for-equity exchange agreements. What Happened: On Friday, Exicure ( XCUR ) filed a Form 8-K with the Securities and Exchange Commission that signaled that it entered into debt-for-equity agreements with DGP and another with a separate individual. DGP, Exicure’s largest shareholder, holds about 35%...
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Sep 16, 2024
Psyence Biomedical Ltd. ( PBM ) , a biotechnology company focused on creating natural psychedelic-based solutions to address mental health challenges, has issued an update to shareholders, highlighting significant recent developments and upcoming milestones. The company has initiated a Phase IIb clinical trial in Australia to evaluate psilocybin-assisted therapy for Adjustment Disorder in palliative care. Results are expected in late...
Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity
Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity
Sep 16, 2024
Over the weekend, Nuvalent, Inc ( NUVL ). highlighted the presentation of updated data from Phase 1 dose-escalation portions of the ongoing ARROS-1 Phase 1/2 trial of zidesamtinib and ALKOVE-1 Phase 1/2 trial of NVL-655, at the European Society for Medical Oncology (ESMO) Congress 2024. In total, 227 patients were enrolled in the Phase 2 portion of the ARROS-1 trial of zidesamtinib...
Copyright 2023-2026 - www.financetom.com All Rights Reserved